Stage IVA Cervical Cancer Active Not Recruiting Phase 2 Trials for Eribulin (DB08871)

IndicationStatusPhase
DBCOND0028785 (Stage IVA Cervical Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01676818Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical CancerTreatment